List of Excipients in API ondansetron hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ondansetron hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | ZOFRAN | ondansetron hydrochloride | 0078-0675 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | ZOFRAN | ondansetron hydrochloride | 0078-0675 | HYPROMELLOSE | |
| Novartis Pharmaceuticals Corporation | ZOFRAN | ondansetron hydrochloride | 0078-0675 | LACTOSE | |
| Novartis Pharmaceuticals Corporation | ZOFRAN | ondansetron hydrochloride | 0078-0675 | MAGNESIUM STEARATE | |
| Novartis Pharmaceuticals Corporation | ZOFRAN | ondansetron hydrochloride | 0078-0675 | STARCH, CORN | |
| Novartis Pharmaceuticals Corporation | ZOFRAN | ondansetron hydrochloride | 0078-0675 | TITANIUM DIOXIDE | |
| Novartis Pharmaceuticals Corporation | ZOFRAN | ondansetron hydrochloride | 0078-0675 | TRIACETIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ondansetron hydrochloride
Detailed excipient profiles for ondansetron hydrochloride
Excipient focus: ANHYDROUS CITRIC ACID
ondansetron hydrochloride drug variants containing ANHYDROUS CITRIC ACID
ondansetron hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
ondansetron hydrochloride drug variants containing ANHYDROUS LACTOSE
ondansetron hydrochloride drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ondansetron hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
ondansetron hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
ondansetron hydrochloride drug variants containing CITRIC ACID MONOHYDRATE
ondansetron hydrochloride drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSCARMELLOSE SODIUM
ondansetron hydrochloride drug variants containing CROSCARMELLOSE SODIUM
ondansetron hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: DEXTROSE
ondansetron hydrochloride drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | ondansetron hydrochloride and dextrose | 0143-9771 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing DEXTROSE
Excipient focus: EDETATE DISODIUM
ondansetron hydrochloride drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | ondansetron hydrochloride | 16714-671 |
| Aurobindo Pharma Limited | ondansetron hydrochloride | 65862-208 |
| NuCare PharmaceuticalsInc | ondansetron hydrochloride | 68071-3611 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing EDETATE DISODIUM
Excipient focus: FERRIC OXIDE RED
ondansetron hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | ondansetron hydrochloride | 0904-6551 |
| Cardinal Health 107 LLC | ondansetron hydrochloride | 55154-7879 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
ondansetron hydrochloride drug variants containing FERRIC OXIDE YELLOW
ondansetron hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: GLYCERIN
ondansetron hydrochloride drug variants containing GLYCERIN
ondansetron hydrochloride drug variants not containing GLYCERIN
Excipient focus: HYPROMELLOSE
ondansetron hydrochloride drug variants containing HYPROMELLOSE
ondansetron hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
ondansetron hydrochloride drug variants containing HYPROMELLOSE 2910
ondansetron hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
ondansetron hydrochloride drug variants containing HYPROMELLOSES
ondansetron hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
ondansetron hydrochloride drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ondansetron hydrochloride | 0078-0675 |
| Taro Pharmaceuticals USA Inc | ondansetron hydrochloride | 51672-4108 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
ondansetron hydrochloride drug variants containing LACTOSE MONOHYDRATE
ondansetron hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LACTOSE, ANHYDROUS
ondansetron hydrochloride drug variants containing LACTOSE, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | ondansetron hydrochloride | 52959-991 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing LACTOSE, ANHYDROUS
Excipient focus: MAGNESIUM STEARATE
ondansetron hydrochloride drug variants containing MAGNESIUM STEARATE
ondansetron hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN
ondansetron hydrochloride drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | ondansetron hydrochloride | 0527-1726 |
| Physicians Total Care Inc | ondansetron hydrochloride | 54868-5888 |
| AuroMedics Pharma LLC | ondansetron hydrochloride | 55150-126 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: POLYETHYLENE GLYCOL
ondansetron hydrochloride drug variants containing POLYETHYLENE GLYCOL
ondansetron hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
ondansetron hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | ondansetron hydrochloride | 21695-834 |
| Physicians Total Care Inc | ondansetron hydrochloride | 54868-5801 |
| Dispensing Solutions Inc | ondansetron hydrochloride | 55045-3729 |
| Dispensing Solutions Inc | ondansetron hydrochloride | 66336-793 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYSORBATE 80
ondansetron hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | ondansetron hydrochloride | 50436-0131 |
| HJ Harkins Company Inc | ondansetron hydrochloride | 52959-991 |
| Bryant Ranch Prepack | ondansetron hydrochloride | 63629-4093 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
ondansetron hydrochloride drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | ondansetron hydrochloride | 51672-4108 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing POLYVINYL ALCOHOL
Excipient focus: PROPYLPARABEN
ondansetron hydrochloride drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | ondansetron hydrochloride | 0527-1726 |
| Physicians Total Care Inc | ondansetron hydrochloride | 54868-5888 |
| AuroMedics Pharma LLC | ondansetron hydrochloride | 55150-126 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM ANHYDROUS
ondansetron hydrochloride drug variants containing SACCHARIN SODIUM ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | ondansetron hydrochloride | 0054-0064 |
| Precision Dose Inc | ondansetron hydrochloride | 68094-763 |
| Carilion Materials Management | ondansetron hydrochloride | 68151-1668 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing SACCHARIN SODIUM ANHYDROUS
Excipient focus: SILICON DIOXIDE
ondansetron hydrochloride drug variants containing SILICON DIOXIDE
ondansetron hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
ondansetron hydrochloride drug variants containing SODIUM BENZOATE
ondansetron hydrochloride drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CHLORIDE
ondansetron hydrochloride drug variants containing SODIUM CHLORIDE
ondansetron hydrochloride drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
ondansetron hydrochloride drug variants containing SODIUM CITRATE
ondansetron hydrochloride drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ondansetron hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
ondansetron hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
ondansetron hydrochloride drug variants containing STARCH, CORN
ondansetron hydrochloride drug variants not containing STARCH, CORN
Excipient focus: SUCRALOSE
ondansetron hydrochloride drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | ondansetron hydrochloride | 50436-4091 |
| Taro Pharmaceuticals USA Inc | ondansetron hydrochloride | 51672-4091 |
| NuCare PharmaceuticalsInc | ondansetron hydrochloride | 68071-1649 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing SUCRALOSE
Excipient focus: SUCROSE
ondansetron hydrochloride drug variants containing SUCROSE
ondansetron hydrochloride drug variants not containing SUCROSE
Excipient focus: TALC
ondansetron hydrochloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | ondansetron hydrochloride | 51672-4108 |
| >Company | >Ingredient | >NDC |
ondansetron hydrochloride drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ondansetron hydrochloride drug variants containing TITANIUM DIOXIDE
ondansetron hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
ondansetron hydrochloride drug variants containing TRIACETIN
ondansetron hydrochloride drug variants not containing TRIACETIN
Excipient focus: TRISODIUM CITRATE DIHYDRATE
ondansetron hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
ondansetron hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
ondansetron hydrochloride drug variants containing WATER
ondansetron hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
